The recent rise in penicillin resistance worldwide has led to the increased use of cephalosporins, macrolides and fluoroquinolones as first line therapies in community-acquired respiratory infections.1 We tested the activity of various antimicrobial agents against clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis at a tertiary hospital in Lebanon.
No takes yet. Share an insight, caveat, or question.
Kanj et al. (2007) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: